Condition: Juvenile Idiopathic Arthritis · Sponsor: Oslo University Hospital
The goal of this clinical trial is to compare three different maintenance and step-down treatment strategies in children and adolescents with juvenile idiopathic arthritis in sustained remission. The main questions it aims to answer are: * Is the proportion of study participants with a disease flare different between each of the two drug withdrawal arms and the stable treatment arm during 12 months? * Does the proportion of study participants with a disease flare differ between the two drug withdrawal arms during 12 months? * How long time does it take before a disease flare occurs, and how long does it take before disease remission is reestablished for participants in the different treatment arms? Participants will be randomized to either A) continued stable treatment with methotrexate and tumor-necrosis alpha inhibitor (TNFi); B) gradual withdrawal of methotrexate while continued stable dose TNFi; or C) gradual withdrawal of TNFi. Participants will be examined every 4 month, and with extra visits if they experience increased symptoms or suspect a disease flare. If a flare occurs, the medications received at study inclusion will be restarted.
This description comes directly from the study's public registry record.
Siri Opsahl Hetlevik, MD PhD · +4795846826 · siri.opsahl@gmail.com
Anna-Birgitte Aga, MD PhD · +4740470692 · anna.birgitte.aga@gmail.com
Always discuss trial participation with your own doctor first.
| Haukeland University Hospital | Bergen, Norway | Recruiting |
| Drammen Hospital | Drammen, Norway | Recruiting |
| Hospital of Southern Norway Hospital Trust | Kristiansand, Norway | Recruiting |
| Oslo University Hospital | Oslo, Norway | Recruiting |
| Stavanger University Hospital | Stavanger, Norway | Recruiting |
| University Hospital of North Norway | Tromsø, Norway | Recruiting |
| St. Olavs Hospital | Trondheim, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653634